9 METERS BIOPHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | 0.00% |
| 25/03 | North American Morning Briefing : Tech in Focus on -2- | DJ |
| 2023 | Bidding Procedure Approved for 9 Meters Biopharma, Inc. | CI |
Sales 2022 by Business Segment
Sales 2022 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
Pharmaceutical Products | |||||||
Total Assets | 6.45M | 5.3M | 39.16M | 50.17M | 33.15M | ||
Interest Expense | -6.15M | -1.83M | -4.05M | -47.19K | -2.67M | ||
CAPEX | -13.94K | -11.93K | -3.19M | -2.51M | -2.84K | ||
EBT | -24.16M | -27.05M | -61.5M | -36.78M | -43.77M | ||
D&A | 19.56K | 21.61K | 18.49K | 7.57K | 8.52K | ||
Operating Income | -18.22M | -25.55M | -60.88M | -36.76M | -42.02M | ||
Net Income | -24.16M | -27.05M | -61.5M | -36.78M | -43.77M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
Total Assets | 6.45M | 5.3M | 39.16M | 50.17M | 33.15M | ||
Interest Expense | -6.15M | -1.83M | -4.05M | -47.19K | -2.67M | ||
D&A | 19.56K | 21.61K | 18.49K | 7.57K | 8.52K | ||
CAPEX | -13.94K | -11.93K | -3.19M | -2.51M | -2.84K | ||
Net Income | -24.16M | -27.05M | -61.5M | -36.78M | -43.77M | ||
EBT | -24.16M | -27.05M | -61.5M | -36.78M | -43.77M | ||
Operating Income | -18.22M | -25.55M | -60.88M | -36.76M | -42.02M |
- Stock Market
- Equities
- NMTRQ Stock
- Financials 9 Meters Biopharma, Inc.
- Business Segments
MarketScreener is also available in this country: United States.
Switch edition